Publication Date: 2018-04-11
Practice Area: Corporate Governance
Industry: Biotechnology | Investments and Investment Advisory
Court: Court of Chancery
Judge: Chancellor Bouchard
Attorneys: For plaintiff: T. Brad Davey and Matthew A. Golden, Potter Anderson & Corroon LLP, Wilmington, DE; Barry S. Pollack and Joshua L. Solomon, Pollack Solomon Duffy LLP, Boston, MA, attorneys for plaintiff
for defendant: Herbert W. Mondros and Krista R. Samis, Margolis Edelstein, Wilmington, DE; Michael f. Bonkowski and Nicholas J. Brannic, Cole Schotz P.C., Wilmington, DE; Roger A. Lane, Courtney Worcester, and Jasmine D. Coo, Foley & Lardner LLP, Boston, MA; Angelica Boutwell, Foley & Lardner LLP, Miami, FL, attorneys for defendants.
Case Number: D68103
Breach of fiduciary duty claims dismissed against parties not part of controlling stockholders control group, but maintained where demand excused by director conflicts that called transaction fairness into question.